Skip to main content
Clinical Trials/NCT05352061
NCT05352061Enrolling By InvitationNot Applicable

Addressing Psychosocial Comorbidities in HIV Treatment and Prevention: Phase 2b

University of Miami2 sites in 1 country75 target enrollmentStarted: August 15, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
75
Locations
2
Primary Endpoint
Percentage of participants who completes the follow up assessment

Study Overview

Brief Summary

The purpose of this study is to learn about ways to better support people living with HIV with their HIV treatment and cope with mental health challenges and/or substance use concerns.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age: 18 years or older
  • HIV positive
  • Evidence of uncontrolled virus (e.g., > 20 copies/ml) within the past 12 months as verified by medical record
  • Group 1: (Men who have sex with men (MSM) who have used stimulants within the past 4 months (approximately 10 participants))OR Group 2: transgender women (approximately 10 participants) OR Group 3: Emerging adults between the ages of 18 and 26 (inclusive; approximately 10 participants)

Exclusion Criteria

  • Unable to provide informed consent due to severe mental or physical illness, cognitive impairment, or substance intoxication at the time of interview
  • Active untreated, unstable, major mental illness (i.e., untreated psychosis or mania) that would interfere with study participation
  • Opinion of the PI that the participant would be at risk for harm to self or others
  • Currently receiving CBT for a psychiatric disorder, or received a course of CBT in the past year.

Arms & Interventions

Cognitive Behavioral Therapy (CBT) for Syndemic and Adherence Factors Group

Experimental

Participants in this group will receive the CBT for Syndemics and Adherence Factors intervention for a total of 14 sessions over 4 months.

Intervention: CBT for Syndemics and Adherence Factors (Behavioral)

Outcomes

Primary Outcomes

Percentage of participants who completes the follow up assessment

Time Frame: 8 months

Feasibility will be reported as the percentage of participants who completes the study follow up assessment.

Secondary Outcomes

  • ART Medication Adherence(Up to 8 months)
  • Percentage of participants with undetectable viral load(Up to 8 months)
  • Percentage of participants with improvement in syndemic, behavioral health outcomes(Up to 8 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Steven Safren

Professor

University of Miami

Study Sites (2)

Loading locations...

Similar Trials